Poly(allylamine)/tripolyphosphate nanocomplex coacervate as a NLRP3-dependent systemic adjuvant for vaccine development
Gastón Rizzo, Rodrigo C. O. Sanches, Camila Chavero, Daiana S. Bianchi, Eugenia Apuzzo, Santiago E. Herrera, Maximiliano L. Agazzi, M. Lorena Cortez, Waldemar A. Marmisollé, Irene Angélica Keitelman, Analia Silvina Trevani, Sergio Costa Oliveira, Omar Azzaroni, Paola Smaldini, Guillermo Horacio Docena
This paper evaluates poly(allylamine)/tripolyphosphate nanocomplex coacervates as a safe systemic adjuvant that activates the NLRP3 inflammasome to enhance Th1-dependent immune responses.
Frontiers in Immunology · Apr 17, 2026Peer-reviewedImmunology